Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2024-08-12 Board/Management Inform…
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Promotion of Mr. Sandeep Kumar from GM to VP, Senior Management Personnel, with effect from 1st April 2024.
Board/Management Information Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the outcome of a Board of Directors meeting held on August 12, 2024. It includes the approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2024, which is a quarterly financial update. Additionally, it announces the re-appointment and appointment of independent directors and a promotion within senior management. The document references compliance with SEBI Listing Regulations and includes an annexure detailing the changes in board and senior management personnel. The primary content is about management changes and board appointments rather than the full financial report itself. The document length is about 6,070 characters, which is relatively short and more consistent with an announcement rather than a full interim report. Therefore, the classification aligns best with Board/Management Information (MANG), as it focuses on changes in the company's board of directors and senior management, along with a brief financial result announcement but not the full report itself.
2024-08-12 English
Appointment of Mr. Ranjit Khattar, as a Non Executive Independent Director, for a term of 5 years, commencing from 12th August 2024, subject to approval of the members at the ensuing annual ....
Board/Management Information Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the outcome of a Board of Directors meeting held on August 12, 2024. It includes approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2024, which is a quarterly financial update. Additionally, it announces re-appointment and appointment of independent directors and a promotion within senior management. The document references compliance with SEBI Listing Regulations and includes an annexure detailing the changes in board and senior management personnel. The primary content is about management changes and financial results for a quarter, but the financial results are only mentioned as approved and enclosed, not detailed in the text. The document is over 6000 characters, so it is not a brief announcement. However, the main focus is on the board meeting outcome and management changes, with financial results mentioned but not fully presented. Given the emphasis on board appointments and management changes, and the nature of the document as a formal intimation under SEBI regulations, the best classification is Board/Management Information (MANG).
2024-08-12 English
Re-appointment of Mr. Praveen Kumar Dutt, as a Non Executive Independent Director, for a second term of 5 year commencing from 13th August 2024, subject to approval of the members as ensuing ....
Board/Management Information Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the outcome of a Board of Directors meeting held on August 12, 2024. It includes approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2024, which is a quarterly financial update. Additionally, it announces re-appointment and appointment of independent directors and a promotion within senior management. The document references compliance with SEBI Listing Regulations and includes an annexure detailing the changes in board and senior management personnel. The primary content is about management changes and board appointments, not the full financial report itself. The financial results are mentioned as approved and enclosed but the document itself is an announcement of these outcomes and appointments. Therefore, the document fits best under Board/Management Information (MANG) as it focuses on board and senior management changes and meeting outcomes rather than the full financial report or earnings release. The document length (6070 characters) and content support this classification with high confidence.
2024-08-12 English
Appointment
Board/Management Information Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the outcome of a Board of Directors meeting held on August 12, 2024. It includes approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2024, which is a quarterly financial update. Additionally, it announces re-appointment and appointment of independent directors and a promotion within senior management. The document references compliance with SEBI Listing Regulations and includes an annexure detailing the changes in board and senior management personnel. The primary content is about management changes and financial results for a quarter, but the financial results are only mentioned as approved and enclosed, not detailed in the text. The document is not a full quarterly report but an announcement of board decisions including management changes and financial results approval. Therefore, the classification best fitting this document is "Board/Management Information (MANG)" because it focuses on board and senior management appointments and promotions, with some financial results approval mentioned but not detailed as a full report. Confidence is high given the clear focus on management changes and board meeting outcomes.
2024-08-12 English
Updates
Board/Management Information Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the outcome of a Board of Directors meeting held on August 12, 2024. It includes approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2024, re-appointment and appointment of independent directors, and promotion of a senior management personnel. The document references compliance with SEBI Listing Regulations and includes an annexure detailing the changes in board and senior management personnel. The primary content is about changes in the board and senior management, not the full financial results report itself. The document length is about 6,070 characters, which is relatively short and more consistent with an announcement rather than a full financial report. Therefore, this filing is best classified as Board/Management Information (MANG).
2024-08-12 English
Appointment
Board/Management Information Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the outcome of a Board of Directors meeting held on August 12, 2024. It includes the approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2024, which is a quarterly financial update. Additionally, it announces the re-appointment and appointment of independent directors and a promotion within senior management. The document references compliance with SEBI Listing Regulations and includes an annexure detailing the changes in board and senior management personnel. The primary content is about management changes and board appointments, not the full financial report itself. The document length is about 6,070 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the document fits best under the category of Board/Management Information (MANG), as it announces changes in the company's board of directors and senior management. The financial results mentioned are summarized and accompanied by a limited review report, but the document itself is not the full quarterly report or earnings release. Confidence in this classification is high due to the clear focus on board and management changes and the regulatory context provided.
2024-08-12 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.